Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis.

Bilsborough W, Keen H, Taylor A, O'Driscoll GJ, Arnolda L, Green DJ. Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int. 2006 Oct; 26(12):1125-31.

View in: PubMed

subject areas

Adult
Antibodies, Monoclonal
Antirheumatic Agents
Arthritis, Rheumatoid
Brachial Artery
Endothelium, Vascular
Female
Humans
Immunoglobulin G
Male
Middle Aged
Receptors, Tumor Necrosis Factor
Regional Blood Flow
Tumor Necrosis Factor-alpha
Vasodilation

authors with profiles

Andrew Taylor, Ph.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support